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*Escherichia coli* is typically considered a harmless commensal bacteria colonizing the mammalian intestine. However, infection by numerous strains from the B2 phylogroup can cause septicemia/bacteremia, urinary tract infection, and meningitis and are increasingly being linked to inflammatory bowel disease and colorectal tumors in humans ([@B1][@B2][@B3]). These strains commonly harbor an \~54-kb polyketide synthetase (PKS) pathogenicity island that produces a genotoxin called colibactin ([@B4], [@B5]). Recently, colibactin expression by the mouse commensal *E. coli* strain NC101 was shown to potentiate colitis-associated colorectal cancer in IL-10^−/−^ mice ([@B2]). Furthermore, aside from causing double-strand DNA breaks, colibactin facilitates intestinal colonization and systemic translocation that causes septicemia and meningitis ([@B6]). Thus, the virulence and oncogenic modalities of colibactin-producing *E. coli* strains in experimental mice may represent a potential confounder of results, especially in models of inflammatory disease and cancer.

In this report, we announce the draft genomes of five novel B2-phylotype *E. coli* strains isolated from the feces of two asymptomatic surveillance mice, the uterine fluid of a transgenic mouse, and from the blood of two experimental immunocompromised mice with sepsis housed under specific-pathogen-free conditions. We previously found all these strains except A4 were PCR-positive for the PKS genes clbA and clbQ and caused megalocytosis and γ-H2AX-detectable DNA damage in HeLa cells *in vitro*, suggesting colibactin activity by these organisms (\[[@B7]\]; our unpublished data). We briefly describe the features of these novel *E. coli* genomes in context to the previously sequenced genomes of NC101 and the PKS-containing septicemia- and meningitis-causing strains IHE3034 and A192PP ([@B4], [@B6]).

Genomes were sequenced using PacBio RSII and resulting sequencing data were assembled into two to five contigs using RS_HGAP_Assembly.3 from the SMRT Portal 2.3. Contigs were annotated using the RAST tool kit (RASTtk) ([@B8]). Novel strains have genomic sizes, G+C content, protein-coding sequences, and RNAs comparable to those of the genomes of NC101 (GenBank: NZ_AEFA00000000.1), IHE3034 (GenBank: NC_017628.1), and A192PP (GenBank: NZ_CVOH00000000.1) ([Table 1](#tab1){ref-type="table"}). All novel genomes except A4 contained complete PKS islands, with all genes having ≥99% sequence identity and coverage as well as identical synteny to those from NC101, IHE3034, and A192PP.

###### 

Genomic characteristics of novel mouse *E. coli* strains

  Strain                                            GenBank accession no.                                              Origin of mouse isolates   Genome size (bp)   No. of contigs   Fold coverage   G+C content (%)   No. of protein-coding sequences   No. of RNA sequences
  ------------------------------------------------- ------------------------------------------------------------------ -------------------------- ------------------ ---------------- --------------- ----------------- --------------------------------- ----------------------
  *E. coli* 1409150006 (MIT A2)                     [MBNU00000000](http://www.ncbi.nlm.nih.gov/nuccore/MBNU00000000)   Feces                      5,292,961          3                114.7           50.5              5,203                             108
  *E. coli* 1409160003 (MIT A4)                     [MBNV00000000](http://www.ncbi.nlm.nih.gov/nuccore/MBNV00000000)   Feces                      5,066,411          4                166.4           50.5              5,003                             114
  *E. coli* 1408270010 (MIT A21)                    [MBNW00000000](http://www.ncbi.nlm.nih.gov/nuccore/MBNW00000000)   Uterine fluid              5,318,023          5                129.9           50.5              5,280                             108
  *E. coli* 1512290008 (Whitehead Institute 0008)   [MBNX00000000](http://www.ncbi.nlm.nih.gov/nuccore/MBNX00000000)   Blood                      5,289,663          3                147.7           50.5              5,203                             108
  *E. coli* 1512290026 (Whitehead Institute 0026)   [MBNY00000000](http://www.ncbi.nlm.nih.gov/nuccore/MBNY00000000)   Blood                      5,005,444          2                140.6           50.6              4,876                             108

PATRIC's proteome comparison service was used to determine the number of homologous genes between NC101, IHE3034, and A192PP as references versus the novel *E. coli* strains ([@B9]). NC101 and the novel PKS-containing strains shared \>4,780 proteins (\>97%) as homologs, whereas between NC101 and A4, 4,732 proteins (\~89%) were homologous. All novel *E. coli* strain shared considerably less homologs to IHE3034 (4,386 to 4,525 proteins; \~87 to 90%) and A192PP (4,472 to 4,624; \~80 to 83%).

Aside from PKS, the virulence factors enterobactin siderophore receptor protein, s-fimbriae minor subunit, glutamate decarboxylase, per-activated serine protease autotransporter enterotoxin, and bor protein precursor were identified in NC101 and the novel PKS-containing strains using VirulenceFinder 1.5 ([@B10]). A4 also contained glutamate decarboxylase, per-activated serine protease autotransporter enterotoxin, and bor protein precursor as well as serine protease autotransporters of *Enterobacteriaceae*.

Together, these genomic data suggest that the novel PKS-containing strains are more similar to NC101 than IHE3034 and A192PP. Future studies will investigate the pathogenic and carcinogenic potential of these and other PKS-containing *E. coli* strains in mice under differing experimental protocols.

Accession number(s). {#s1}
--------------------

The genome sequences have been submitted to GenBank under the accession numbers listed in [Table 1](#tab1){ref-type="table"}.
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